Table of Contents
Journal of Signal Transduction
Volume 2011, Article ID 869281, 10 pages
http://dx.doi.org/10.1155/2011/869281
Review Article

Receptor Tyrosine Kinases in Kidney Development

Section of Pediatric Nephrology, Department of Pediatrics, Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, LA 70112, USA

Received 25 November 2010; Revised 8 January 2011; Accepted 15 January 2011

Academic Editor: Karl Matter

Copyright © 2011 Renfang Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Tufro, J. Teichman, N. Banu, and G. Villegas, “Crosstalk between VEGF-A/VEGFR2 and GDNF/RET signaling pathways,” Biochemical and Biophysical Research Communications, vol. 358, no. 2, pp. 410–416, 2007. View at Publisher · View at Google Scholar · View at PubMed
  2. I. V. Yosypiv, M. Schroeder, and S. S. El-Dahr, “Angiotensin II type 1 receptor-EGF receptor cross-talk regulates ureteric bud branching morphogenesis,” Journal of the American Society of Nephrology, vol. 17, no. 4, pp. 1005–1014, 2006. View at Publisher · View at Google Scholar · View at PubMed
  3. R. Song, M. Spera, C. Garrett, and I. V. Yosypiv, “Angiotensin II-induced activation of c-Ret signaling is critical in ureteric bud branching morphogenesis,” Mechanisms of Development, vol. 127, no. 1-2, pp. 21–27, 2010. View at Publisher · View at Google Scholar · View at PubMed
  4. M. A. Basson, J. Watson-Johnson, R. Shakya et al., “Branching morphogenesis of the ureteric epithelium during kidney development is coordinated by the opposing functions of GDNF and Sprouty1,” Developmental Biology, vol. 299, no. 2, pp. 466–477, 2006. View at Publisher · View at Google Scholar · View at PubMed
  5. I. V. Yosypiv, M. K. Boh, M. A. Spera, and S. S. El-Dahr, “Downregulation of Spry-1, an inhibitor of GDNF/Ret, causes angiotensin II-induced ureteric bud branching,” Kidney International, vol. 74, no. 10, pp. 1287–1293, 2008. View at Publisher · View at Google Scholar · View at PubMed
  6. L. Saxen, Organogenesis of the Kidney, Cambridge University Press, Cambridge, UK, 1987.
  7. A. Schedl, “Renal abnormalities and their developmental origin,” Nature Reviews Genetics, vol. 8, no. 10, pp. 791–802, 2007. View at Publisher · View at Google Scholar · View at PubMed
  8. F. Costantini and R. Kopan, “Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development,” Developmental Cell, vol. 18, no. 5, pp. 698–712, 2010. View at Publisher · View at Google Scholar · View at PubMed
  9. P. Ekblom, “Developmentally regulated conversion of mesenchyme to epithelium,” FASEB Journal, vol. 3, no. 10, pp. 2141–2150, 1989. View at Google Scholar
  10. C. Grobstein, “Inductive epithelio-mesenchymal interaction in cultured organ rudiments of the mouse,” Science, vol. 118, no. 3054, pp. 52–55, 1953. View at Google Scholar
  11. E. Batourina, C. Choi, N. Paragas et al., “Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and Ret,” Nature Genetics, vol. 32, no. 1, pp. 109–115, 2002. View at Publisher · View at Google Scholar · View at PubMed
  12. E. Batourina, S. Tsai, S. Lambert et al., “Apoptosis induced by vitamin A signaling is crucial for connecting the ureters to the bladder,” Nature Genetics, vol. 37, no. 10, pp. 1082–1089, 2005. View at Publisher · View at Google Scholar · View at PubMed
  13. K. Stark, S. Vainio, G. Vassileva, and A. P. McMahon, “Epithelial transformation metanephric mesenchyme in the developing kidney regulated by Wnt-4,” Nature, vol. 372, no. 6507, pp. 679–683, 1994. View at Google Scholar
  14. T. J. Carroll, J. S. Park, S. Hayashi, A. Majumdar, and A. P. McMahon, “Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system,” Developmental Cell, vol. 9, no. 2, pp. 283–292, 2005. View at Publisher · View at Google Scholar · View at PubMed
  15. D. M. Iglesias, P. A. Hueber, L. Chu et al., “Canonical WNT signaling during kidney development,” American Journal of Physiology, vol. 293, no. 2, pp. F494–F500, 2007. View at Publisher · View at Google Scholar · View at PubMed
  16. A. Kobayashi, M. T. Valerius, J. W. Mugford et al., “Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development,” Cell Stem Cell, vol. 3, no. 2, pp. 169–181, 2008. View at Publisher · View at Google Scholar · View at PubMed
  17. B. M. Brenner, D. L. Garcia, and S. Anderson, “Glomeruli and blood pressure. Less of one, more the other?” American Journal of Hypertension, vol. 1, no. 4, pp. 335–347, 1988. View at Google Scholar
  18. S. J. M. Lisle, R. M. Lewis, C. J. Petry, S. E. Ozanne, C. N. Hales, and A. J. Forhead, “Effect of maternal iron restriction during pregnancy on renal morphology in the adult rat offspring,” British Journal of Nutrition, vol. 90, no. 1, pp. 33–39, 2003. View at Publisher · View at Google Scholar
  19. J. Schlessinger, “Cell signaling by receptor tyrosine kinases,” Cell, vol. 103, no. 2, pp. 211–225, 2000. View at Google Scholar
  20. P. Blume-Jensen and T. Hunter, “Oncogenic kinase signalling,” Nature, vol. 411, no. 6835, pp. 355–365, 2001. View at Publisher · View at Google Scholar · View at PubMed
  21. A. Boulay, M. Breuleux, C. Stephan et al., “The ret receptor tyrosine kinase pathway functionally interacts with the ERα pathway in breast cancer,” Cancer Research, vol. 68, no. 10, pp. 3743–3751, 2008. View at Publisher · View at Google Scholar · View at PubMed
  22. T. Iwashita, K. Kurokawa, S. Qiao et al., “Functional analysis of RET with Hirschsprung mutations affecting its kinase domain,” Gastroenterology, vol. 121, no. 1, pp. 24–33, 2001. View at Google Scholar
  23. M. A. Lemmon and J. Schlessinger, “Cell signaling by receptor tyrosine kinases,” Cell, vol. 141, no. 7, pp. 1117–1134, 2010. View at Publisher · View at Google Scholar · View at PubMed
  24. H. D. Madhani, “Accounting for specificity in receptor tyrosine kinase signaling,” Cell, vol. 106, no. 1, pp. 9–11, 2001. View at Publisher · View at Google Scholar
  25. L. G. Cantley and L. C. Cantly, “Signal transduction by the hepatocyte growth factor receptor, c-met: activation of the phosphatidylinositol 3-kinase,” Journal of the American Society of Nephrology, vol. 5, no. 11, pp. 1872–1881, 1995. View at Google Scholar
  26. A. Schuchardt, V. D'Agati, L. Larsson-Blornberg, F. Costantini, and V. Pachnis, “Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret,” Nature, vol. 367, no. 6461, pp. 380–384, 1994. View at Publisher · View at Google Scholar · View at PubMed
  27. H. Zhao, H. Kegg, S. Grady et al., “Role of fibroblast growth factor receptors 1 and 2 in the ureteric bud,” Developmental Biology, vol. 276, no. 2, pp. 403–415, 2004. View at Publisher · View at Google Scholar · View at PubMed
  28. D. Hains, S. Sims-Lucas, K. Kish, M. Saha, K. Mchugh, and C. M. Bates, “Role of fibroblast growth factor receptor 2 in kidney mesenchyme,” Pediatric Research, vol. 64, no. 6, pp. 592–598, 2008. View at Publisher · View at Google Scholar · View at PubMed
  29. Z. Zhang, E. Pascuet, P. A. Hueber et al., “Targeted inactivation of EGF receptor inhibits renal collecting duct development and function,” Journal of the American Society of Nephrology, vol. 21, no. 4, pp. 573–578, 2010. View at Publisher · View at Google Scholar · View at PubMed
  30. S. Ishibe, A. Karihaloo, H. Ma et al., “Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology,” Development, vol. 136, no. 2, pp. 337–345, 2009. View at Publisher · View at Google Scholar · View at PubMed
  31. X. Gao, X. Chen, M. Taglienti, B. Rumballe, M. H. Little, and J. A. Kreidberg, “Angioblast-mesenchyme induction of early kidney development is mediated by Wt1 and Vegfa,” Development, vol. 132, no. 24, pp. 5437–5449, 2005. View at Publisher · View at Google Scholar · View at PubMed
  32. A. Tufro, V. F. Norwood, R. M. Carey, and R. A. Gomez, “Vascular endothelial growth factor induces nephrogenesis and vasculogenesis,” Journal of the American Society of Nephrology, vol. 10, no. 10, pp. 2125–2134, 1999. View at Google Scholar
  33. A. Marlier, K. M. Schmidt-Ott, A. R. Gallagher, J. Barasch, and A. Karihaloo, “Vegf as an epithelial cell morphogen modulates branching morphogenesis of embryonic kidney by directly acting on the ureteric bud,” Mechanisms of Development, vol. 126, no. 3-4, pp. 91–98, 2009. View at Publisher · View at Google Scholar · View at PubMed
  34. X. Li, A. Pontén, K. Aase et al., “PDGF-C is a new protease-activated ligand for the PDGF α-receptor,” Nature Cell Biology, vol. 2, no. 5, pp. 302–307, 2000. View at Publisher · View at Google Scholar · View at PubMed
  35. P. Soriano, “Abnormal kidney development and hematological disorders in PDGF β- receptor mutant mice,” Genes and Development, vol. 8, no. 16, pp. 1888–1896, 1994. View at Google Scholar
  36. A. Karihaloo, D. A. O'Rourke, C. Nickel, K. Spokes, and L. G. Cantley, “Differential MAPK pathways utilized for HGF- and EGF-dependent renal epithelial morphogenesis,” Journal of Biological Chemistry, vol. 276, no. 12, pp. 9166–9173, 2001. View at Publisher · View at Google Scholar · View at PubMed
  37. H. Sakurai, T. Tsukamoto, C. A. Kjelsberg, L. G. Cantley, and S. K. Nigam, “EGF receptor ligands are a large fraction of in vitro branching morphogens secreted by embryonic kidney,” American Journal of Physiology, vol. 273, no. 3, pp. F463–F472, 1997. View at Google Scholar
  38. J. Qiao, R. Uzzo, T. Obara-Ishihara, L. Degenstein, E. Fuchs, and D. Herzlinger, “FGF-7 modulates ureteric bud growth and nephron number in the developing kidney,” Development, vol. 126, no. 3, pp. 547–554, 1999. View at Google Scholar
  39. U. Grieshammer, C. Cebrián, R. Ilagan, E. Meyers, D. Herzlinger, and G. R. Martin, “FGF8 is required for cell survival at distinct stages of nephrogenesis and for regulation of gene expression in nascent nephrons,” Development, vol. 132, no. 17, pp. 3847–3857, 2005. View at Publisher · View at Google Scholar · View at PubMed
  40. A. O. Perantoni, O. Timofeeva, F. Naillat et al., “Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development,” Development, vol. 132, no. 17, pp. 3859–3871, 2005. View at Publisher · View at Google Scholar · View at PubMed
  41. H. Ohuchi, Y. Hori, M. Yamasaki et al., “FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development,” Biochemical and Biophysical Research Communications, vol. 277, no. 3, pp. 643–649, 2000. View at Publisher · View at Google Scholar · View at PubMed
  42. M. P. Sanchez, I. Silos-Santiago, J. Frisén, B. He, S. A. Lira, and M. Barbacid, “Renal agenesis and the absence of enteric neurons in mice lacking GDNF,” Nature, vol. 382, no. 6586, pp. 70–73, 1996. View at Publisher · View at Google Scholar · View at PubMed
  43. H. Sakurai, E. J. Barros, T. Tsukamoto, J. Barasch, and S. K. Nigam, “An in vitro tubulogenesis system using cell lines derived from the embryonic kidney shows dependence on multiple soluble growth factors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 12, pp. 6279–6284, 1997. View at Publisher · View at Google Scholar
  44. P. Levéen, M. Pekny, S. Gebre-Medhin, B. Swolin, E. Larsson, and C. Betsholtz, “Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities,” Genes and Development, vol. 8, no. 16, pp. 1875–1887, 1994. View at Google Scholar
  45. V. Eremina, M. Sood, J. Haigh et al., “Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases,” Journal of Clinical Investigation, vol. 111, no. 5, pp. 707–716, 2003. View at Publisher · View at Google Scholar
  46. E. Sonnenberg, A. Godecke, B. Walter, F. Bladt, and C. Birchmeier, “Transient and locally restricted expression of the ros1 protooncogene during mouse development,” EMBO Journal, vol. 10, no. 12, pp. 3693–3702, 1991. View at Google Scholar
  47. E. Sonnenberg-Riethmacher, B. Walter, D. Riethmacher, S. Gödecke, and C. Birchmeier, “The c-ros tyrosine kinase receptor controls regionalization and differentiation of epithelial cells in the epididymis,” Genes and Development, vol. 10, no. 10, pp. 1184–1193, 1996. View at Google Scholar
  48. P. D. Brophy, L. Ostrom, K. M. Lang, and G. R. Dressler, “Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene,” Development, vol. 128, no. 23, pp. 4747–4756, 2001. View at Google Scholar
  49. X. Chi, O. Michos, R. Shakya et al., “Ret-dependent cell rearrangements in the Wolffian duct epithelium initiate ureteric bud morphogenesis,” Developmental Cell, vol. 17, no. 2, pp. 199–209, 2009. View at Publisher · View at Google Scholar · View at PubMed
  50. V. Pachnis, B. Mankoo, and F. Costantini, “Expression of the c-ret proto-oncogene during mouse embryogenesis,” Development, vol. 119, no. 4, pp. 1005–1017, 1993. View at Google Scholar
  51. M. A. Skinner, S. D. Safford, J. G. Reeves, M. E. Jackson, and A. J. Freemerman, “Renal aplasia in humans is associated with RET mutations,” American Journal of Human Genetics, vol. 82, no. 2, pp. 344–351, 2008. View at Publisher · View at Google Scholar · View at PubMed
  52. J. C. Clarke, S. R. Patel, R. M. Raymond Jr. et al., “Regulation of c-Ret in the developing kidney is responsive to Pax2 gene dosage,” Human Molecular Genetics, vol. 15, no. 23, pp. 3420–3428, 2006. View at Publisher · View at Google Scholar · View at PubMed
  53. C. Rosselot, L. Spraggon, I. Chia et al., “Non-cell-autonomous retinoid signaling is crucial for renal development,” Development, vol. 137, no. 2, pp. 283–292, 2010. View at Publisher · View at Google Scholar · View at PubMed
  54. M. Takahashi, “The GDNF/RET signaling pathway and human diseases,” Cytokine and Growth Factor Reviews, vol. 12, no. 4, pp. 361–373, 2001. View at Publisher · View at Google Scholar
  55. S. Jain, “The many faces of RET dysfunction in kidney,” Organogenesis, vol. 5, no. 4, pp. 1–14, 2009. View at Google Scholar
  56. M. S. Airaksinen and M. Saarma, “The GDNF family: signalling, biological functions and therapeutic value,” Nature Reviews Neuroscience, vol. 3, no. 5, pp. 383–394, 2002. View at Publisher · View at Google Scholar · View at PubMed
  57. S. Jain, M. Encinas, E. M. Johnson, and J. Milbrandt, “Critical and distinct roles for key RET tyrosine docking sites in renal development,” Genes and Development, vol. 20, no. 3, pp. 321–333, 2006. View at Publisher · View at Google Scholar · View at PubMed
  58. S. Jain, A. Knoten, M. Hoshi et al., “Organotypic specificity of key RET adaptor-docking sites in the pathogenesis of neurocristopathies and renal malformations in mice,” Journal of Clinical Investigation, vol. 120, no. 3, pp. 778–790, 2010. View at Publisher · View at Google Scholar · View at PubMed
  59. C. V. Pepicelli, A. Kispert, D. H. Rowitch, and A. P. McMahon, “Rapid communication: GDNF induces branching and increased cell proliferation in the ureter of the mouse,” Developmental Biology, vol. 192, no. 1, pp. 193–198, 1997. View at Publisher · View at Google Scholar · View at PubMed
  60. L. Michael and J. A. Davies, “Pattern and regulation of cell proliferation during murine ureteric bud development,” Journal of Anatomy, vol. 204, no. 4, pp. 241–255, 2004. View at Publisher · View at Google Scholar · View at PubMed
  61. T. N. Meyer, C. Schwesinger, K. T. Bush et al., “Spatiotemporal regulation of morphogenetic molecules during in vitro branching of the isolated ureteric bud: toward a model of branching through budding in the developing kidney,” Developmental Biology, vol. 275, no. 1, pp. 44–67, 2004. View at Publisher · View at Google Scholar · View at PubMed
  62. S. Kuure, C. Cebrian, Q. Machingo et al., “Actin depolymerizing factors cofilin1 and destrin are required for ureteric bud branching morphogenesis,” PLoS Genetics, vol. 6, no. 10, pp. 1–11, 2010. View at Publisher · View at Google Scholar · View at PubMed
  63. S. Kuure, X. Chi, B. Lu, and F. Costantini, “The transcription factors Etv4 and Etv5 mediate formation of the ureteric bud tip domain during kidney development,” Development, vol. 137, no. 12, pp. 1975–1979, 2010. View at Publisher · View at Google Scholar · View at PubMed
  64. C. J. Powers, S. W. McLeskey, and A. Wellstein, “Fibroblast growth factors, their receptors and signaling,” Endocrine-Related Cancer, vol. 7, no. 3, pp. 165–197, 2000. View at Google Scholar
  65. E. Arman, R. Haffner-Krausz, Y. Chen, J. K. Heath, and P. Lonai, “Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 9, pp. 5082–5087, 1998. View at Publisher · View at Google Scholar
  66. C. X. Deng, A. Wynshaw-Boris, M. M. Shen, C. Daugherty, D. M. Ornitz, and P. Leder, “Murine FGFR-1 is required for early postimplantation growth and axial organization,” Genes and Development, vol. 8, no. 24, pp. 3045–3057, 1994. View at Google Scholar
  67. J. Qiao, K. T. Bush, D. L. Steer et al., “Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis,” Mechanisms of Development, vol. 109, no. 2, pp. 123–135, 2001. View at Publisher · View at Google Scholar
  68. H. Ohuchi, Y. Hori, M. Yamasaki et al., “FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development,” Biochemical and Biophysical Research Communications, vol. 277, no. 3, pp. 643–649, 2000. View at Publisher · View at Google Scholar · View at PubMed
  69. S. Sims-Lucas, L. Cullen-McEwen, V. P. Eswarakumar et al., “Deletion of Frs2α from the ureteric epithelium causes renal hypoplasia,” American Journal of Physiology, vol. 297, no. 5, pp. F1208–F1219, 2009. View at Publisher · View at Google Scholar · View at PubMed
  70. M. R. Passos-Bueno, W. R. Wilcox, E. W. Jabs, A. L. Sertié, L. G. Alonso, and H. Kitoh, “Clinical spectrum of fibroblast growth factor receptor mutations,” Human Mutation, vol. 14, no. 2, pp. 115–125, 1999. View at Google Scholar
  71. A. Maeshima, D. A. Vaughn, Y. Choi, and S. K. Nigam, “Activin A is an endogenous inhibitor of ureteric bud outgrowth from the Wolffian duct,” Developmental Biology, vol. 295, no. 2, pp. 473–485, 2006. View at Publisher · View at Google Scholar · View at PubMed
  72. O. Michos, C. Cebrian, D. Hyink et al., “Kidney development in the absence of Gdnf and Spry1 requires Fgf10,” PLoS Genetics, vol. 6, no. 1, Article ID e1000809, 11 pages, 2010. View at Publisher · View at Google Scholar · View at PubMed
  73. V. P. Eswarakumar, I. Lax, and J. Schlessinger, “Cellular signaling by fibroblast growth factor receptors,” Cytokine and Growth Factor Reviews, vol. 16, no. 2, pp. 139–149, 2005. View at Publisher · View at Google Scholar · View at PubMed
  74. B. C. Lu, C. Cebrian, X. Chi et al., “Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis,” Nature Genetics, vol. 41, no. 12, pp. 1295–1302, 2009. View at Publisher · View at Google Scholar · View at PubMed
  75. T. Holbro and N. E. Hynes, “ErbB receptors: directing key signaling networks throughout life,” Annual Review of Pharmacology and Toxicology, vol. 44, pp. 195–217, 2004. View at Publisher · View at Google Scholar · View at PubMed
  76. W. B. W. H. Melenhorst, G. M. Mulder, QI. Xi et al., “Epidermal growth factor receptor signaling in the kidney key roles in physiology and disease,” Hypertension, vol. 52, no. 6, pp. 987–993, 2008. View at Publisher · View at Google Scholar · View at PubMed
  77. N. Bernardini, F. Bianchi, M. Lupetti, and A. Dolfi, “Immunohistochemical localization of the epidermal growth factor, transforming growth factor α, and their receptor in the human mesonephros and metanephros,” Developmental Dynamics, vol. 206, no. 3, pp. 231–238, 1996. View at Google Scholar
  78. D. W. Threadgill, A. A. Dlugosz, L. A. Hansen et al., “Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype,” Science, vol. 269, no. 5221, pp. 230–234, 1995. View at Google Scholar
  79. A. S. Woolf, A. S. Kolatsi-Joannou, P. Hardman et al., “Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros,” Journal of Cell Biology, vol. 128, no. 1-2, pp. 171–184, 1995. View at Google Scholar
  80. C. Schmidt, F. Bladt, S. Goedecke et al., “Scatter factor/hepatocyte growth factor is essential for liver development,” Nature, vol. 373, no. 6516, pp. 699–702, 1995. View at Google Scholar
  81. Y. Liu, N. Chattopadhyay, S. Qin et al., “Coordinate integrin and c-Met signaling regulate Wnt gene expression during epithelial morphogenesis,” Development, vol. 136, no. 5, pp. 843–853, 2009. View at Publisher · View at Google Scholar · View at PubMed
  82. S. Ishibe, D. Joly, X. Zhu, and L. G. Cantley, “Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis,” Molecular Cell, vol. 12, no. 5, pp. 1275–1285, 2003. View at Publisher · View at Google Scholar
  83. S. Ishibe, J. E. Haydu, A. Togawa, A. Marlier, and L. G. Cantley, “Cell confluence regulates hepatocyte growth factor-stimulated cell morphogenesis in a β-catenin-dependent manner,” Molecular and Cellular Biology, vol. 26, no. 24, pp. 9232–9243, 2006. View at Publisher · View at Google Scholar · View at PubMed
  84. A. Karihaloo, C. Nickel, and L. G. Cantley, “Signals which build a tubule,” Nephron Experimental Nephrology, vol. 100, no. 1, pp. e40–e45, 2005. View at Google Scholar
  85. L. E. O'Brien, K. Tang, E. S. Kats, A. Schutz-Geschwender, J. H. Lipschutz, and K. E. Mostov, “ERK and MMPs sequentially regulate distinct stages of epithelial tubule development,” Developmental Cell, vol. 7, no. 1, pp. 21–32, 2004. View at Publisher · View at Google Scholar · View at PubMed
  86. N. Ferrara, “Vascular endothelial growth factor: basic science and clinical progress,” Endocrine Reviews, vol. 25, no. 4, pp. 581–611, 2004. View at Publisher · View at Google Scholar · View at PubMed
  87. J. Kanellis, S. J. Mudge, S. Fraser, M. Katerelos, and D. A. Power, “Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemia-reperfusion injury,” Kidney International, vol. 57, no. 6, pp. 2445–2456, 2000. View at Publisher · View at Google Scholar · View at PubMed
  88. P. Lindahl, M. Hellström, M. Kalén et al., “Paracrine PDGF-B/PDGF-Rβ signaling controls mesangial cell development in kidney glomeruli,” Development, vol. 125, no. 17, pp. 3313–3322, 1998. View at Google Scholar
  89. C. H. Heldin, A. Östman, and L. Rönnstrand, “Signal transduction via platelet-derived growth factor receptors,” Biochimica et Biophysica Acta, vol. 1378, no. 1, pp. F79–F113, 1998. View at Publisher · View at Google Scholar
  90. F. Eitner, T. Ostendorf, M. Kretzler et al., “PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases,” Journal of the American Society of Nephrology, vol. 14, no. 5, pp. 1145–1153, 2003. View at Publisher · View at Google Scholar
  91. T. Nakagawa, K. Izumino, Y. Ishii et al., “Roles of PDGF receptor-beta in the structure and function of postnatal kidney glomerulus,” Nephrology Dialysis Transplantation, vol. 26, no. 2, pp. 458–468, 2011. View at Publisher · View at Google Scholar · View at PubMed
  92. M. R. Hammerman and S. Rogers, “Distribution of IGF receptors in the plasma membrane of proximal tubular cells,” American Journal of Physiology, vol. 253, no. 5, pp. F841–F847, 1987. View at Google Scholar
  93. J. P. Duong Van Huyen, K. Amri, M. F. Bélair et al., “Spatiotemporal distribution of insulin-like growth factor receptors during nephrogenesis in fetuses from normal and diabetic rats,” Cell and Tissue Research, vol. 314, no. 3, pp. 367–379, 2003. View at Publisher · View at Google Scholar · View at PubMed
  94. S. A. Rogers, G. Ryan, and M. R. Hammerman, “Insulin-like growth factors I and II are produced in the metanephros and are required for growth and development in vitro,” Journal of Cell Biology, vol. 113, no. 6, pp. 1447–1453, 1991. View at Google Scholar
  95. M. P. Bueno, D. Guadagnini, F. L.L. Gonçalves et al., “Assessment of the expression of IRβ, IRS-1, IRS-2 and IGF-IRβ in a rat model of intrauterine growth restriction,” Fetal Diagnosis and Therapy, vol. 28, no. 3, pp. 145–152, 2010. View at Publisher · View at Google Scholar · View at PubMed
  96. I. V. Yosypiv, “Renin-angiotensin system-growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis,” Pediatric Nephrology, vol. 24, no. 6, pp. 1113–1120, 2009. View at Publisher · View at Google Scholar · View at PubMed
  97. K. Oshima, Y. Miyazaki, J. W. Brock, M. C. Adams, I Ichikawa, and J. C. Pope, “Angiotensin type II receptor expression and ureteral budding,” Journal of Urology, vol. 166, no. 5, pp. 1848–1852, 2001. View at Google Scholar
  98. M. Lacoste, Y. Cai, L. Guicharnaud et al., “Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: role of the renin-angiotensin system,” Journal of the American Society of Nephrology, vol. 17, no. 8, pp. 2253–2263, 2006. View at Publisher · View at Google Scholar · View at PubMed
  99. V. Besset, R. P. Scott, and C. F. Ibáñez, “Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase,” Journal of Biological Chemistry, vol. 275, no. 50, pp. 39159–39166, 2000. View at Publisher · View at Google Scholar · View at PubMed